Sivextro (tedizolid) / Merck (MSD), Nabriva Therap  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sivextro (tedizolid) / Merck (MSD), Nabriva Therap
ABSSSI, NCT03176134 / 2016-003884-20: A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Completed
3
100
Europe, US, RoW
Tedizolid phosphate, MK-1986, TR-701 FA, Comparator
Merck Sharp & Dohme LLC
Acute Bacterial Skin and Skin Structure Infections
07/23
07/23

Download Options